Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06304493 · ClinicalTrials.gov registry record · NA
REMINDers for Incentive Spirometry in PACU (REMIND-IS in PACU)
A NA study of Respiratory Insufficiency and Post Operative Pulmonary Complications, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT06304493: Completed NA study of Respiratory Insufficiency and Post Operative Pulmonary Complications, sponsored by University of Colorado, Denver.
NCT06304493 is a NA study of Respiratory Insufficiency and Post Operative Pulmonary Complications that has completed, run by University of Colorado, Denver. The registered enrollment target is 240 participants, below the 727-participant average among 10 other Respiratory Insufficiency trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06304493, a NA study of Respiratory Insufficiency and Post Operative Pulmonary Complications, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if the frequency of use of incentive spirometry during the stay in the Post-Anesthesia Care Unit (PACU) increases with visual and auditory electronic reminders, as compared to not having those reminders.
Primary Outcome
Rate of adequate incentive spirometry breaths achieved by patients per hour for up to 3 hours during the PACU stay
Conditions Studied
Interventions
- DEVICE Alarms
Study Locations (1)
Colorado
- CU Anschutz - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2024-03-25 |
| Est. Completion | 2024-10-03 |
| Phase | NA |
What the finished NCT06304493 record still lists
NCT06304493 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 727-participant average among 10 other Respiratory Insufficiency trials with a reported enrollment target (67% lower).
The record links to 8 conditions, with Respiratory Insufficiency appearing as the primary indexed condition, and to 1 intervention - of which Alarms is the first listed.
NCT06304493 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06304493 about?
NCT06304493 is a clinical study titled "REMINDers for Incentive Spirometry in PACU (REMIND-IS in PACU)". The purpose of this study is to determine if the frequency of use of incentive spirometry during the stay in the Post-Anesthesia Care Unit (PACU) increases with visual and auditory electronic reminders, as compared to not having those reminders.
What is the current status of trial NCT06304493?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2024-03-25. Estimated completion is 2024-10-03.
What conditions does trial NCT06304493 study?
This clinical trial studies the following conditions: Respiratory Insufficiency, Post Operative Pulmonary Complications, Respiratory Therapy, Incentive Spirometry, Patient Adherence.
What interventions are being tested in trial NCT06304493?
The interventions under investigation include: Alarms (DEVICE).
Who is sponsoring clinical trial NCT06304493?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06304493 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Insufficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06304493's enrollment target sits among peer trials
240 3rd of 10 higher than 8 of 10 other Respiratory Insufficiency trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Respiratory Insufficiency trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Platform of Randomized Adaptive Clinical Trials in Critical Illness
RECRUITING · NA
-
Multicenter HomeVENT: Home Values and Experiences Navigation Track
RECRUITING · NA
-
Combined Respiratory Training in Persons With ALS
RECRUITING · NA
-
Delayed Cord Clamping With Oxygen In Extremely Low Gestation Infants
ACTIVE NOT RECRUITING · NA
-
Flow-synchronized Nasal IMV in Preterm Infants
COMPLETED · NA
-
Behavioral Activation-Rehabilitation to Improve Depressive Symptoms & Physical Function After Acute Respiratory Failure
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI